ClinicalTrials.Veeva

Menu

The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section

T

Trakya University

Status and phase

Completed
Phase 4

Conditions

Caesarean Section
Anesthesia; Reaction

Treatments

Drug: Bupivacaine
Drug: Sevoflurane

Study type

Interventional

Funder types

Other

Identifiers

NCT03134677
TUTF-GOKAEK 2014/116

Details and patient eligibility

About

This study evaluates the effects of different anesthetic techniques on QT, QTc, and Pwd in cesarean section. Half of participants received general anesthesia, while the other half received spinal anesthesia Electrocardiography (ECG) recordings were performed at preoperative, 5, 15, 30 min after initiation anesthesia and 30 min post-operatively. Hemodynamic state were also recorded at the same time intervals. QT, corrected QT (QTc), QT dispersion (QTd), QTc dispersion (QTcd), P-wave dispersion (Pwd), corrected JT interval, T wave (Tp-e), transmular dispersion of repolarization durations were measured from ECG records at predetermined time intervals of spinal or general anesthesia.

Full description

The anesthetic drugs used according general or regional anesthesia techniques can display proarrhythmic and antiarrhythmic effects by inducing cardiac electrical signals with different pathways.In addition, comorbid disease, hormonal changes, surgery procedures, and drug therapy can all cause arrhythmia in the intraoperative period. Likewise, pregnancy causes many changes hormonal and physiological in women. Hemodynamic and hormonal changes during pregnancy can cause effects proarrhythmogenic that cause premature atrial and ventricular beats to develop.

Enrollment

90 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. American Society of Anesthesiologists physical status I-II
  2. ages 20-40 years
  3. parturient patients

Exclusion criteria

  1. spinal cord and peripheral nervous system diseases;
  2. hypovolemic and hemorrhagic shock;
  3. increased intracranial pressure;
  4. severe anemia;
  5. systemic infection;
  6. scoliosis;
  7. congenital spinal anomalies;
  8. vertebral colon metastatic lesions;
  9. anticoagulant drug use;
  10. diabetes mellitus;
  11. hypo/hyperthyroidism;
  12. atrial and/or ventricular hypertrophy on ECG;
  13. cardiomyopathy;
  14. valvular disease;
  15. cardiac failure or chronic disease;
  16. cardiomegaly
  17. used medication causing QT interval prolongation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups

Bupivacaine
Experimental group
Description:
We were performed spinal anesthesia sitting position by midline. After confirming the free flow of cerebrospinal fluid, bupivacaine was administered without aspiration.ECG recordings were performed at preoperative, 5, 15, and 30 minutes after initial anesthesia and 30 minutes post-operatively.
Treatment:
Drug: Bupivacaine
Sevoflurane
Experimental group
Description:
We were performed general anesthesia with sevoflurane. Anesthesia was maintained with 2-3% sevoflurane. ECG recordings were performed at preoperative, 5, 15, and 30 minutes after initial anesthesia and 30 minutes post-operatively.
Treatment:
Drug: Sevoflurane

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems